The Latest Breaking News from Nasdaq

Within the last quarter, Monster Beverage (NASDAQ:MNST) has observed the following analyst ratings:

Barclays has decided to maintain its Overweight rating of Ligand Pharmaceuticals (NASDAQ:LGND) and lower its price target from $165.00 to $157.00. Shares of Ligand Pharmaceuticals are trading up 1.79% over the last 24 hours, at $92.20 per share.

Chinook Therapeutics, Inc. (NASDAQ: KDNY) announced that the European Commission has granted orphan drug designation for BION-1301 for the treatment of primary IgA nephropathy (IgAN).

Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.

Communications and social media company DatChat, Inc (NASDAQ:DATS) closed on the previously announced acquisition of Avila Security Corporation.  DatChat issued 1 million shares, subject to a lock-up agreement. The transaction terms included $1 million in cash and the greater of 739,650 shares or $2.5 million of stock. The transaction expands DatChat's intellectual property assets by…

Barclays analyst Ross Sandler acknowledged that investors were "rightfully wary" about the trajectory of digital advertising growth in 2022, especially into Q2 earnings. 

Ayala Pharmaceuticals Inc (NASDAQ:AYLA) announced interim results from Part A of the ongoing RINGSIDE Phase 2/3 trial evaluating AL102 in desmoid tumors.  MRI scans showed decreases in tumor size in most of the 13 patients who had reached the 16-week point. One patient reached an unconfirmed partial response at week 16. AL102 was…

Atlas Technical Consultants Inc (NASDAQ:ATCX) has secured a three-year, $18 million Architectural and Engineering on-call Quality Assurance and Inspection Services contract from the California Department of Transportation (Caltrans) in various counties in Southern California. Atlas will support the Caltrans Division of Engineering Services, Material Engineering, and Testing Services (METS) on all capital projects…

A whale with a lot of money to spend has taken a noticeably bullish stance on Datadog. Looking at options history for Datadog (NASDAQ:DDOG) we detected 19 strange trades.

InMed Pharmaceuticals Inc. (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is taking a leading position in the marketplace.

The animated feature “Minions: The Rise of Gru” from Comcast Corp.’s (NASDAQ: CMCSA) Universal Pictures in conjunction with Illumination wrapped up the four-day Independence Day weekend with $125.1 million in U.S.